What is the address of MEDIGEN?

The registered office of MEDIGEN is located at Venelle des Trois Sapins 2 box a, 1410 Waterloo.

Is MEDIGEN still active?

Yes. According to the CBE (30 October 2026) MEDIGEN is active, legal situation “Normale toestand”, started on 28 June 1988.

Is MEDIGEN registered on Peppol?

Yes, MEDIGEN is registered on the Peppol network with ID 0208:0434769143.

What is the enterprise number of MEDIGEN?

The enterprise number of MEDIGEN is BE0434769143.

When was MEDIGEN founded?

MEDIGEN was founded on 28 June 1988.

Who are the directors of MEDIGEN?

According to the 2025 annual accounts, the directors of MEDIGEN are: Michel Hanset.

Is MEDIGEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 June 1988; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDIGEN make in 2025?

MEDIGEN posted a profit after taxes of € 51,308 in financial year 2025.

What is the revenue of MEDIGEN?

As a small company, MEDIGEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 80,051.

MEDIGEN (Private Limited) - Waterloo - BE0434769143

Dossier MEDIGEN, printed on 30 October 2026 from databakkes.be/en/0434769143/medigen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDIGEN from Waterloo, company number BE0434769143, closed financial year 2025 with a result of € 51,308 after tax. For that financial year MEDIGEN recorded a gross margin of € 80,051 and equity of € 317,899. Compared with financial year 2024, the result moved from € 72,955 to € 51,308. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 18, 2026.

What it is worth Healthy

€ 317,899

▼ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 51,308

▼ 30% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 227,166

▲ 67% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 80,833 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 11,284

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 83

▼ 64% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 6,056

▲ 140% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,102

▼ 10% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 97,730 Gross margin 2022: € 97,730 First fiscal year in the series	€ 76,598 Gross margin 2023: € 76,598 ▼ 22% vs 2022 (€ 97,730) Unfavourable step	€ 109,689 Gross margin 2024: € 109,689 ▲ 43% vs 2023 (€ 76,598) Favourable step	€ 80,051 Gross margin 2025: € 80,051 ▼ 27% vs 2024 (€ 109,689) Unfavourable step	▼ 27%
Profit after taxes	€ 56,975 Profit after taxes 2022: € 56,975 First fiscal year in the series	€ 47,247 Profit after taxes 2023: € 47,247 ▼ 17% vs 2022 (€ 56,975) Unfavourable step	€ 72,955 Profit after taxes 2024: € 72,955 ▲ 54% vs 2023 (€ 47,247) Favourable step	€ 51,308 Profit after taxes 2025: € 51,308 ▼ 30% vs 2024 (€ 72,955) Unfavourable step	▼ 30%
Equity	€ 258,222 Equity 2022: € 258,222 First fiscal year in the series	€ 287,469 Equity 2023: € 287,469 ▲ 11% vs 2022 (€ 258,222) Favourable step	€ 347,424 Equity 2024: € 347,424 ▲ 21% vs 2023 (€ 287,469) Favourable step	€ 317,899 Equity 2025: € 317,899 ▼ 8% vs 2024 (€ 347,424) Unfavourable step	▼ 8%
Total debts	€ 25,365 Total debts 2022: € 25,365 First fiscal year in the series	€ 25,592 Total debts 2023: € 25,592 ▲ 1% vs 2022 (€ 25,365) Unfavourable step	€ 21,874 Total debts 2024: € 21,874 ▼ 15% vs 2023 (€ 25,592) Favourable step	€ 93,075 Total debts 2025: € 93,075 ▲ € 71,201 vs 2024 (€ 21,874) Unfavourable step	▲ € 71,201
Cash	€ 100,151 Cash 2022: € 100,151 First fiscal year in the series	€ 111,312 Cash 2023: € 111,312 ▲ 11% vs 2022 (€ 100,151) Favourable step	€ 135,880 Cash 2024: € 135,880 ▲ 22% vs 2023 (€ 111,312) Favourable step	€ 227,166 Cash 2025: € 227,166 ▲ 67% vs 2024 (€ 135,880) Favourable step	▲ 67%
Retained profit	€ 245,525 Retained profit 2022: € 245,525 First fiscal year in the series	€ 274,772 Retained profit 2023: € 274,772 ▲ 12% vs 2022 (€ 245,525) Favourable step	€ 334,727 Retained profit 2024: € 334,727 ▲ 22% vs 2023 (€ 274,772) Favourable step	€ 305,202 Retained profit 2025: € 305,202 ▼ 9% vs 2024 (€ 334,727) Unfavourable step	▼ 9%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 18,000 Dividend 2023: € 18,000 Unchanged (€ 0) Unchanged	€ 13,000 Dividend 2024: € 13,000 ▼ 28% vs 2023 (€ 18,000) Unchanged	€ 80,833 Dividend 2025: € 80,833 ▲ € 67,833 vs 2024 (€ 13,000) Unchanged	▲ € 67,833
Bank debt	€ 750 Bank debt 2022: € 750 First fiscal year in the series	€ 70 Bank debt 2023: € 70 ▼ 91% vs 2022 (€ 750) Favourable step	€ 230 Bank debt 2024: € 230 ▲ 229% vs 2023 (€ 70) Unfavourable step	€ 83 Bank debt 2025: € 83 ▼ 64% vs 2024 (€ 230) Favourable step	▼ 64%
Balance sheet total	€ 283,587 Balance sheet total 2022: € 283,587 First fiscal year in the series	€ 313,062 Balance sheet total 2023: € 313,062 ▲ 10% vs 2022 (€ 283,587) Unchanged	€ 369,298 Balance sheet total 2024: € 369,298 ▲ 18% vs 2023 (€ 313,062) Unchanged	€ 410,974 Balance sheet total 2025: € 410,974 ▲ 11% vs 2024 (€ 369,298) Unchanged	▲ 11%

Key figures of MEDIGEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDIGEN?

What happened at MEDIGEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 18, 2026 New annual accounts for financial year 2025: profit of € 51,308 (▼ 30% vs 2024). Source: NBB ↗
Jun 28, 1988 New establishment in Waterloo. KBO
1988 Michel Hanset became a director. NBB
Jun 28, 1988 Start of the company according to the CBE. KBO

In short

From € 56,975 profit in 2022 to € 51,308 profit in 2025.

Paid € 105,760 in corporate taxes since 2022.

Best year ever: 2024, with € 72,955 profit.

Paid out € 111,833 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Michel Hanset

MEDIGEN

Behind MEDIGEN is Michel Hanset.

Directors

According to the 2025 annual accounts

Michel Hanset

Director

since 1988

Establishments

Establishment units

Physical locations of this company

Registered office

Venelle des Trois Sapins 2 box a

1410 Waterloo

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Association des copropriétaires de la Résidence Auteuil

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0434.769.143
VAT number: BE 0434.769.143
Registered office: Venelle des Trois Sapins 2 bus a, 1410 Waterloo
Names & denominations: MEDIGEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 June 1988
Peppol: Active · Active since 17 Mar 2026

View on CBE Public ↗ Annual accounts (NBB) ↗